Cellular DNA (DNA) (DNA)

Cellular DNA serves as the primary therapeutic target for alkylating agents such as cyclophosphamide. Cyclophosphamide is a nitrogen mustard prodrug that requires metabolic activation by hepatic cytochrome P450 enzymes (primarily CYP2B6) to form its active cytotoxic metabolite, phosphoramide mustard (StatPearls, 2023). This active species covalently modifies DNA by attaching alkyl groups, most frequently at the N7 position of guanine, which facilitates the creation of lethal DNA-DNA interstrand and intrastrand cross-links (PubChem, 2024). These structural modifications disrupt the double helix, effectively blocking the progression of DNA and RNA polymerases, which halts essential processes like replication and transcription. In rapidly dividing cells, such as those found in hematologic malignancies and solid tumors, the accumulation of these DNA lesions activates damage-response pathways that lead to programmed cell death or apoptosis (NCI Drug Dictionary). Beyond its role in oncology, the modification of DNA in activated lymphocytes allows cyclophosphamide to function as a potent immunosuppressant for treating severe autoimmune disorders and preventing organ transplant rejection.

Other names

Deoxyribonucleic acidGenomic DNADNA adductsAlkylated DNAN7-guanine DNA adducts

Cyclophosphamide is a prodrug converted by hepatic cytochrome P450 enzymes into phosphoramide mustard, which acts as a bifunctional alkylating agent. It covalently binds to the N7 position of guanine residues in cellular DNA, leading to the formation of interstrand and intrastrand cross-links. These cross-links physically prevent DNA strand separation, thereby inhibiting DNA replication and RNA transcription, which triggers cell cycle arrest and apoptosis (StatPearls, 2023; PubChem CID 2907).